iRhythmvsMerck & Company

IRTC and MRK stock compared: price, dividend, valuation and results, from SEC filings.

IRTC

iRhythm Holdings, Inc.

$97.70

Value $3.2B

+2.98%
IRTC's page

MRK

Merck & Company, Inc.

$133.84

Value $331B

-2.99%
MRK's page

iRhythm (IRTC) has a market value of $3.2B and Merck & Company (MRK) $331B. Over the last year, with dividends, IRTC moved -42.4% and MRK +42.7%. Dividend yield: IRTC none, MRK 2.54%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    IRTC$3.2B

    MRK$331B

    MRK is 105 times IRTC

  • Revenue, 12 months

    IRTC$854M

    MRK$67.4B

    MRK is 79 times IRTC

  • Net income, 12 months

    IRTC-$39M

    MRK$2.5B

  • Operating margin

    IRTC-5.7%

    MRK–

  • ROIC

    IRTC-4.8%

    MRK3.9%

    8.7 points apart

  • P/E

    IRTC–

    MRK134.9

  • Dividend yield

    IRTC0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    IRTC-3.6%

    MRK+87.5%

    91.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

IRTC-3.6%

MRK+87.5%

5010015020020222023202420252026
Returns by period
PeriodIRTCWith dividendsMRKWith dividends
1 year since November 18, 2025-42.4%Price -42.4%+42.7%Price +38.6%
3 years since November 17, 2023+19.9%+6.2% a yearPrice +19.9%+44.0%+12.9% a yearPrice +31.4%
5 years since November 18, 2021-3.6%-0.7% a yearPrice -3.6%+87.5%+13.4% a yearPrice +61.0%
10 years since November 21, 2016+226.0%+12.5% a yearPrice +226.0%+205.1%+11.8% a yearPrice +124.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

IRTCiRhythmMRKMerck & Company

Valuation

IRTCMRK
Valuation
Price$97.70$133.84
Market value$3.2B$331B
Enterprise value (EV)$3.3B$375B
P/E–134.9
P/E, 5-year median–14.8
P/B17.87.4
EV/EBIT–78.8
Free cash flow yield0.4%4.5%

Results and growth

IRTCMRK
Results and growth
Revenue, 12 months$854M$67.4B
Net income, 12 months-$39M$2.5B
Free cash flow, 12 months$11M$14.7B
Earnings per share, 12 months-$1.16$0.98
Revenue growth, year on year26.2%1.3%
Revenue growth a year, past+23.0%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

IRTCMRK
Margins and returns on capital
Gross margin72.3%71.8%
Operating margin-5.7%–
Net margin-4.5%3.6%
ROIC-4.8%3.9%
ROE-24.2%5.2%

Balance sheet

IRTCMRK
Balance sheet
Cash$467M$9.7B
Total debt$726M$53.8B
Net debt / EBITDA–5.7
Interest cover-3.7×2.4×

Dividends and buybacks

IRTCMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: IRTC or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, iRhythm or Merck & Company?

By market value, Merck & Company ($331B) is about 104.8 times iRhythm ($3.2B), at today's prices.

How did IRTC and MRK stock do over the last 10 years?

Since November 21, 2016, IRTC's price moved +226.0% and MRK's +124.9%. With dividends: IRTC +226.0% (+12.5% a year), MRK +205.1% (+11.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, IRTC or MRK?

The dividend yield at today's price is none for iRhythm and 2.54% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, iRhythm or Merck & Company?

Over the last twelve months, the net margin was -4.5% for iRhythm and 3.6% for Merck & Company, and the operating margin -5.7% and –. Revenue was $854M and $67.4B.

Which is the better investment, iRhythm or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.